Miranda Fox

Miranda Fox possesses extensive experience in clinical operations and trial management, having held various significant roles at leading biopharmaceutical organizations. As Associate Director of Clinical Operations at Inhibrx Biosciences, Inc. from September 2021 to July 2025, Miranda led study activities, developed study documents, and oversaw clinical trial operations. Prior to this, Miranda served as a Clinical Trial Manager and Project Manager at PPD, where responsibilities included coordinating multidisciplinary teams and managing project timelines and budgets across multiple studies. Additional expertise includes managing global studies in cardiovascular and oncology indications at ICON plc, and leading a large phase IV global study at Quintiles. Miranda holds a Bachelor of Science in Biochemistry from North Carolina State University and a Clinical Trials Certification from Durham Technical Community College.